Vertex Pharmaceuticals' GAAP net income for 2022 was $3.322 billion, up 41.8% from $2.342 billion in the previous year. Revenues increased 17.9% to $8.931 billion from $7.574 billion a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept